Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

J. Araujo · SciRah

Researcher profile · Semantic Scholar

J. Araujo

Share profile

J. Araujo — researcher profile on SciRah

h-index: 26
Works: 108
Citations: 4,539

Most-cited papers

Personalized Oncology Through Integrative High-Throughput Sequencing: A Pilot Study
S. Roychowdhury, M. Iyer, D. Robinson, Robert J. Lonigro +23 more
2011Science Translational Medicine625 citations Open access
Semantic Scholar
Platinum-Based Chemotherapy for Variant Castrate-Resistant Prostate Cancer
A. Aparicio, A. Harzstark, P. Corn, S. Wen +13 more
2013Clinical Cancer Research433 citations Open access
Semantic Scholar
Meta-Analysis Evaluating the Impact of Site of Metastasis on Overall Survival in Men With Castration-Resistant Prostate Cancer.
S. Halabi, W. Kelly, Huangbin Ma, Haojin Zhou +21 more
2016Journal of Clinical Oncology412 citations Open access
Semantic Scholar
Neoadjuvant PD-L1 plus CTLA-4 blockade in patients with cisplatin-ineligible operable high-risk urothelial carcinoma
Jian-Jun Gao, N. Navai, O. Alhalabi, A. Siefker-Radtke +27 more
2020Nature Medicine285 citations Open access
Semantic Scholar
Dasatinib: a potent SRC inhibitor in clinical development for the treatment of solid tumors.
J. Araujo, C. Logothetis
2010Cancer Treatment Reviews237 citations Open access
Semantic Scholar
Clonal expansion of CD8 T cells in the systemic circulation precedes development of ipilimumab-induced toxicities
S. Subudhi, A. Aparicio, Jian-Jun Gao, A. Zurita +13 more
2016Proceedings of the National Academy of Sciences of the United States of America220 citations Open access
Semantic Scholar
Docetaxel and dasatinib or placebo in men with metastatic castration-resistant prostate cancer (READY): a randomised, double-blind phase 3 trial
J. Araujo, G. C. Trudel, F. Saad, A. Armstrong +21 more
2013The Lancet Oncology219 citations Open access
Semantic Scholar
A phase 2 trial of sunitinib in patients with advanced non-clear cell renal cell carcinoma
N. Tannir, E. Plimack, C. Ng, P. Tamboli +10 more
2012European Urology161 citations Open access
Semantic Scholar
Dasatinib Combined With Docetaxel For Castration-Resistant Prostate Cancer: Results From a Phase 1/2 Study
J. Araujo, P. Mathew, A. Armstrong, E. Braud +7 more
2011Cancer150 citations Open access
Semantic Scholar
Prognostic Factors in Patients Treated with 223Ra: The Role of Skeletal Tumor Burden on Baseline 18F-Fluoride PET/CT in Predicting Overall Survival
E. Etchebehere, J. Araujo, P. Fox, N. Swanston +2 more
2015Journal of Nuclear Medicine124 citations Open access
Semantic Scholar
Overall Survival of Black and White Men With Metastatic Castration-Resistant Prostate Cancer Treated With Docetaxel.
S. Halabi, Sandipan Dutta, C. Tangen, M. Rosenthal +15 more
2019Journal of Clinical Oncology121 citations Open access
Semantic Scholar
Src signaling pathways in prostate cancer
Andreas S. Varkaris, A. Katsiampoura, J. Araujo, G. Gallick +1 more
2014Cancer Metastasis Review103 citations Open access
Semantic Scholar
The Src Family Kinase/Abl Inhibitor Dasatinib Suppresses Proliferation and Enhances Differentiation of Osteoblasts
Yu-Chen Lee, Chih-Fen Huang, M. Murshed, K. Chu +6 more
2010Oncogene87 citations Open access
Semantic Scholar
Determination of Skeletal Tumor Burden on 18F-Fluoride PET/CT
E. Rohren, E. Etchebehere, J. Araujo, B. Hobbs +4 more
2015Journal of Nuclear Medicine77 citations Open access
Semantic Scholar
The MD Anderson prostate cancer patient-derived xenograft series (MDA PCa PDX) captures the molecular landscape of prostate cancer and facilitates marker-driven therapy development
N. Palanisamy, Jun Yang, Peter D. A. Shepherd, E. Li-Ning-Tapia +19 more
2020Clinical Cancer Research74 citations Open access
Semantic Scholar
Targeting Src signaling in metastatic bone disease
J. Araujo, C. Logothetis
2009International Journal of Cancer60 citations Open access
Semantic Scholar
Dasatinib and docetaxel combination treatment for patients with castration-resistant progressive prostate cancer: A phase I/II study (CA180086).
J. Araujo, A. Armstrong, E. Braud, E. Posadas +6 more
2016Journal of Clinical Oncology58 citations
Semantic Scholar
Factors affecting 223Ra therapy: clinical experience after 532 cycles from a single institution
E. Etchebehere, D. Milton, J. Araujo, N. Swanston +2 more
2015European Journal of Nuclear Medicine and Molecular Imaging57 citations
Semantic Scholar
Overall survival (OS) and safety of dasatinib/docetaxel versus docetaxel in patients with metastatic castration-resistant prostate cancer (mCRPC): Results from the randomized phase III READY trial.
J. Araujo, G. C. Trudel, F. Saad, A. Armstrong +16 more
2013Journal of Clinical Oncology56 citations
Semantic Scholar
Dasatinib inhibits both osteoclast activation and prostate cancer PC-3 cell-induced osteoclast formation
J. Araujo, A. Poblenz, Paul G. Corn, N. Parikh +5 more
2009Cancer Biology & Therapy49 citations Open access
Semantic Scholar
Skeletal Tumor Burden on Baseline 18F-Fluoride PET/CT Predicts Bone Marrow Failure After 223Ra Therapy
E. Etchebehere, J. Araujo, D. Milton, W. Erwin +5 more
2016Clinical Nuclear Medicine39 citations
Semantic Scholar
Taxane-based Combination Therapies for Metastatic Prostate Cancer.
P. Corn, N. Agarwal, J. Araujo, G. Sonpavde
2017European Urology Focus34 citations
Semantic Scholar
Marine- and plant-derived ω-3 fatty acids differentially regulate prostate cancer cell proliferation.
P. Eser, J. P. Vanden Heuvel, J. Araujo, Jerry T. Thompson
2013Molecular and clinical oncology34 citations Open access
Semantic Scholar
Targeting of CYP17A1 Lyase by VT-464 Inhibits Adrenal and Intratumoral Androgen Biosynthesis and Tumor Growth of Castration Resistant Prostate Cancer
S. Maity, Mark Titus, R. Gyftaki, Guanglin Wu +6 more
2016Scientific Reports33 citations Open access
Semantic Scholar
External Validation of a Prognostic Model of Overall Survival in Men With Chemotherapy-Naïve Metastatic Castration-Resistant Prostate Cancer
S. Halabi, Qian-yu Yang, Akash Roy, B. Luo +16 more
2023Journal of Clinical Oncology26 citations Open access
Semantic Scholar
Enzalutamide in Combination with Abiraterone Acetate in Bone Metastatic Castration-resistant Prostate Cancer Patients
E. Efstathiou, Mark Titus, S. Wen, P. Troncoso +8 more
2019European Urology Oncology22 citations Open access
Semantic Scholar
Long-term use of dasatinib in patients with metastatic castration-resistant prostate cancer after receiving the combination of dasatinib and docetaxel
J. Araujo, G. C. Trudel, Prashni Paliwal
2013Cancer Management and Research20 citations Open access
Semantic Scholar
Abiraterone acetate plus prednisone in non-metastatic biochemically recurrent castration-naïve prostate cancer.
N. Spetsieris, M. Boukovala, I. Alafis, John B. Davis +14 more
2021European Journal of Cancer18 citations
Semantic Scholar
A pilot presurgical study evaluating anti-PD-L1 durvalumab (durva) plus anti-CTLA-4 tremelimumab (treme) in patients (pts) with high-risk muscle-invasive bladder carcinoma (MIBC) who are ineligible for cisplatin-based neoadjuvant chemotherapy (NAC).
Jian-Jun Gao, A. Siefker-Radtke, N. Navai, M. Campbell +16 more
2019Journal of Clinical Oncology17 citations
Semantic Scholar
A phase II trial of Abiraterone followed by randomization to addition of Dasatinib or Sunitinib in men with metastatic castration resistant prostate cancer.
N. Spetsieris, M. Boukovala, J. Weldon, A. Tsikkinis +16 more
2020Clinical Genitourinary Cancer15 citations Open access
Semantic Scholar
The combination of serum insulin, osteopontin, and hepatocyte growth factor predicts time to castration-resistant progression in androgen dependent metastatic prostate cancer- an exploratory study
F. Dayyani, A. Zurita, G. Nogueras-González, R. Slack +5 more
2016BMC Cancer15 citations Open access
Semantic Scholar
A multi-institutional randomized phase II study (NCT01505868) of cabazitaxel (CAB) plus or minus carboplatin (CARB) in men with metastatic castration-resistant prostate cancer (mCRPC).
P. Corn, S. Tu, A. Zurita, S. Subudhi +10 more
201515 citations
Semantic Scholar
Is interim 18F-fluoride PET/CT a predictor of outcomes after radium-223 therapy?
E. Etchebehere, A. E. Brito, K. Kairemo, E. Rohren +2 more
2019Radiologia Brasileira9 citations Open access
Semantic Scholar
The oral CYP17-Lyase (L) inhibitor VT-464 in patients with CRPC.
J. de Bono, C. Pezaro, S. Gillessen, N. Shore +10 more
20159 citations
Semantic Scholar
Phase II trial of Pemetrexed plus Gemcitabine in patients with advanced non-clear cell renal cell carcinoma
S. Richey, P. Tamboli, C. Ng, E. Lin +6 more
2013American Journal of Clinical Oncology9 citations Open access
Semantic Scholar
Comparative Survival of Asian and White Metastatic Castration-Resistant Prostate Cancer Men Treated With Docetaxel
S. Halabi, Sandipan Dutta, C. Tangen, M. Rosenthal +14 more
2020JNCI Cancer Spectrum8 citations Open access
Semantic Scholar
Clinical predictors of survival in patients with castration-resistant prostate cancer receiving sipuleucel-T cellular immunotherapy
M. A. Bilen, K. Hess, S. Subudhi, A. Aparicio +8 more
2017Cancer Chemotherapy and Pharmacology8 citations
Semantic Scholar
Neoadjuvant trial of sunitinib malate and androgen ablation (ADT) in patients with localized prostate cancer (PCa) at high risk for recurrence.
A. Zurita, J. Ward, J. Araujo, CurtisA Pettaway +4 more
2011Journal of Clinical Oncology8 citations
Semantic Scholar
Outcomes of patients with intermediate-risk or poor-risk metastatic renal cell carcinoma who received their first cycle of nivolumab and ipilimumab in the hospital because of symptomatic disease: The MD Anderson Cancer Center experience
O. Alhalabi, E. Hasanov, N. Wilson, J. Araujo +7 more
2021International Journal of Cancer7 citations Open access
Semantic Scholar
Randomized phase II study of olaparib (Ola) maintenance following cabazitaxel-carboplatin induction chemotherapy (CabCarb) in men with aggressive variant prostate cancer (AVPC).
P. Pilié, Rebecca S. Slack Tidwell, Paul V. Viscuse, S. Subudhi +10 more
2023Journal of Clinical Oncology6 citations
Semantic Scholar
Prostate cancer castrate resistant progression usage of non-canonical androgen receptor signaling and ketone body fuel
E. Labanca, Juan Bizzotto, P. Sanchis, N. Anselmino +16 more
2021Oncogene6 citations Open access
Semantic Scholar
A candidate androgen signaling signature predictive of response to Abiraterone acetate in men with metastatic castration resistant prostate cancer
M. Boukovala, N. Spetsieris, J. Weldon, A. Tsikkinis +15 more
2020European Journal of Cancer6 citations Open access
Semantic Scholar
OUTCOMES OF NON-METASTATIC MICROPAPILLARY VARIANT UPPER TRACT UROTHELIAL CARCINOMA
J. Duplisea, F. Petros, Roger Li, B. Fellman +6 more
2019Urologic oncology6 citations Open access
Semantic Scholar
A pilot pre-surgical study evaluating anti-PD-L1 durvalumab (durva) plus anti-CTLA-4 tremelimumab (treme) in patients with muscle-Invasive, high-risk urothelial bladder carcinoma who are ineligible for cisplatin-based neoadjuvant chemotherapy.
Jian-Jun Gao, A. Siefker-Radtke, N. Navai, M. Campbell +15 more
20186 citations
Semantic Scholar
Overall survival between African-American (AA) and Caucasian (C) men with metastatic castration-resistant prostate cancer (mCRPC).
S. Halabi, Sandipan Dutta, C. Tangen, M. Rosenthal +16 more
2018Journal of Clinical Oncology6 citations
Semantic Scholar
A randomized study of finite abiraterone acetate (AA) plus leuprolide (LHRHa) versus LHRHa in biochemically recurrent non metastatic hormone naïve prostate cancer (M0HNPC).
E. Efstathiou, Xue-Mei Wang, A. Zurita, S. Tu +9 more
20185 citations
Semantic Scholar
Leuprolide monotherapy for choroidal metastasis from prostate adenocarcinoma.
H. Ameri, J. Araujo, D. Gombos
2012A M A Archives of Ophthalmology5 citations Open access
Semantic Scholar
Tu1734 RANDOMIZED CLINICAL TRIAL OF INFLIXIMAB VERSUS VEDOLIZUMAB FOR IMMUNE CHECKPOINT INHIBITOR RELATED COLITIS
Ying-Hong Wang, Krishnavathana Varatharajalu, Malek Shatila, A. Thomas +9 more
2023Gastroenterology4 citations
Semantic Scholar
Linking tumor mutational load to clinical responses to ipilimumab (IPI) in men with advanced prostate cancer (PCa).
S. Subudhi, A. Aparicio, P. Troncoso, Jian-Hua Zhang +14 more
20174 citations
Semantic Scholar
A prospective, multicenter, randomized phase II trial of best systemic therapy (BST) or BST plus definitive treatment (Surgery or Radiation) of the primary tumor in metastatic prostate cancer.
B. Chapin, S. McGuire, Xue-Mei Wang, P. Troncoso +14 more
20154 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

C. Logothetis×26
Invite
C. Logothetis — researcher profile on SciRah
P. Corn×14
Invite
P. Corn — researcher profile on SciRah
A. Aparicio×13
Invite
A. Aparicio — researcher profile on SciRah
A. Zurita×12
Invite
A. Zurita — researcher profile on SciRah

×12

Invite

E. Efstathiou — researcher profile on SciRah

Invite

S. Subudhi — researcher profile on SciRah

Invite

S. Tu — researcher profile on SciRah

Invite

P. Troncoso — researcher profile on SciRah

Invite

J. de Bono — researcher profile on SciRah

Invite

M. Morris — researcher profile on SciRah

Invite

J. Wang — researcher profile on SciRah

Invite

L. Pagliaro — researcher profile on SciRah